MedTrace Logo

Osteolysis of Allograft Prosthetic Composite After Shoulder Resection for Tumors

NCT06382792 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 6

Last updated 2024-04-24

No results posted yet for this study

Summary

The gold standard after shoulder resection for tumors is reconstruction by reverse prosthesis and allograft. This is an intervention also performed for more frequent etiologies (revisions of prosthesis, non cancerous humeral bone loss ...).

The results in these etiologies are good, and do not find any particular mechanical complications (including no osteolysis of the graft). In the case of reconstruction for cancer, the numbers of patients are lower (rare pathologies) and some studies on small numbers found osteolysis of the allograft. The aim of this study is to analyze the presence or not osteolysis in these patients, and to quantify it precisely by scanner measurement (no data yet in the literature).

Conditions

  • Shoulder Disease

Interventions

PROCEDURE

proximal humeral resection for tumor and allograft prosthetic composite reconstruction

allograft prosthetic composite

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Principal Investigators

  • Sirveaux FRANCOIS · Central Hopital, Nancy France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2024-05-01
Completion
2024-05-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06382792 on ClinicalTrials.gov